USPTO TTABVUE. Trademark Trial and Appeal Board Inquiry System

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

TTABVUE. Trademark Trial and Appeal Board Inquiry System

v2.5.0

Summary

Query: Party Name contains all words: GLAXO GROUP, LIMITED
Number of results: 100+
Results are in reverse chronological order

Proceeding
Filing Date

Defendant(s),
Property(ies)

Plaintiff(s),
Property(ies)

98449745
11/12/2024

GLAXO GROUP LIMITED
Mark: O ORZELIA S#:98449745

Bristol-Myers Squibb Company

98449739
11/12/2024

GLAXO GROUP LIMITED
Mark: ORZELIA S#:98449739

Bristol-Myers Squibb Company

97782421
01/05/2024

Glaxo Group Limited
Mark: AUVIZRI S#:97782421

Axsome Therapeutics, Inc.

97235603
01/02/2023

Glaxo Group Limited
Mark: IQROSMA S#:97235603

Novartis AG

97235566
11/30/2022

Glaxo Group Limited
Mark: SPEFKO S#:97235566

Boehringer Ingelheim International GmbH

97073216
09/22/2022

Glaxo Group Limited
Mark: UPLUNIR S#:97073216

Astellas US LLC

97021933
08/25/2022

Glaxo Group Limited
Mark: JUVENRIO S#:97021933

ABBOTT LABORATORIES

90556913
05/02/2022

KOWA COMPANY, LTD.
Mark: VANTELIN S#:90556913

Glaxo Group Limited

79293448
01/11/2022

Nippi, Incorporated
Mark: IMATRIX S#:79293448

Glaxo Group Limited

79294807
06/29/2021

Nuclera Nucleics Ltd
Mark: NUCLERA S#:79294807

Glaxo Group Limited

88728807
05/05/2021

Glaxo Group Limited
Mark: LENQUO S#:88728807

Novartis AG

79279473
05/20/2020

Glaxo Group Limited
Mark: QUBALYN S#:79279473

Merck Sharp & Dohme Corp.

88406770
04/30/2020

Glaxo Group Limited
S#:88406770

Sandoz Inc.

88406760
04/30/2020

Glaxo Group Limited
S#:88406760

Sandoz Inc.

88644914
02/12/2020

Eli Lilly and Company
Mark: ZULROQ S#:88644914

Sage Therapeutics, Inc.
Glaxo Group Limited

79270827
01/22/2020

ALENSA, s.r.o.
Mark: ALENSA S#:79270827

Glaxo Group Limited

79261301
12/06/2019

Glaxo Group Limited
Mark: LUMYDE S#:79261301

BAUSCH & LOMB INCORPORATED

88035461
07/22/2019

Phibro Animal Health Corporation
Mark: REJENSA S#:88035461

Glaxo Group Limited

92071574
06/21/2019

Glaxo Group Limited
Mark: NOZERUS S#:86461271 R#:4869493

Tricida, Inc.

88228343
05/03/2019

International Biophysics Corporation
Mark: AFFLOVENT S#:88228343

Glaxo Group Limited

88191437
04/29/2019

Glaxo Group Limited
Mark: ARYOV S#:88191437

Novartis AG

79249980
04/16/2019

Novartis AG
Mark: JUVOQUE S#:79249980

Glaxo Group Limited

88122734
04/09/2019

Golden DAPU (Xiamen) Biotech Co., Ltd.
Mark: TUCANA S#:88122734

Glaxo Group Limited

88056800
02/19/2019

Respirent Pharmaceuticals Co.,Ltd.
Mark: SERIVAIR S#:88056800

Glaxo Group Limited

88057453
02/19/2019

Respirent Pharmaceuticals Co.,Ltd.
Mark: BI-VAIR S#:88057453

Glaxo Group Limited
Glaxo Group Limited